Rally for Normative Demands and Solidarity of Workers

This research is initiated by an interesting fact that there are still many labor strikes and rallies in Indonesia. The purpose of this study is to determine: the influence of normative demands and solidarity together on job dissatisfaction of workers. This research is intended as explanatory research. Sampling method used in this research is accidental sampling. The sample consists of 100 workers/laborers who joined rallies on May 1, 2014. The results show on the indicator the amount of City Minimum Wage Rates in normative demands variable, respondents believe the amount of wages earned are still not in accordance with the provisions of the minimum wage set by the government. Participation of workers in the fight for economic security must be done in various ways including demonstrations, based on solidarity between workers in order to put pressure on policy makers with regard to labor issues. In conclusion, good normative demands in accordance with the provisions of the agreement and the strong solidarity between workers will reduce dissatisfaction. Suggestions are made on normative demands variable; review should be made on the amount of the city minimum wage rates; leave entitlements, workers social security and dismissal policies should be in compliance with the current government policy

Additional file 2: of The risk associated with spinal manipulation: an overview of reviews

PRISMA harm checklist. (PDF 28 kb

Additional file 4: of The risk associated with spinal manipulation: an overview of reviews

Reference lists for the excluded reviews. (PDF 365 kb

Variables according to development of anti-TNFi Ab production following 6 months of treatment with adalimumab or infliximab.

<p>Variables according to development of anti-TNFi Ab production following 6 months of treatment with adalimumab or infliximab.</p

Changes in levels of IL-6, sTNF-R1 and sTNF-R2 following 6 months of treatment with adalimumab or infliximab.

<p>Level of IL-6 and sTNF-R1 and sTNF-R2 were determined in 26 patients with rheumatoid arthritis, 15 patients treated with adalimumab, and 11 patients treated with infliximab. Levels were determined prior to treatment (Baseline) and following 6 months of treatment (Follow-up). Levels of IL-6 (A) and sTNF-R2 (C) decreased significantly during treatment. *<i>p</i> < 0.05. Medians and interquartile ranges are shown.</p

Flow diagram of the selection of patients in this study.

<p>Patients were recruited among all patients diagnosed with rheumatoid arthritis and treated with a TNFi, with serum samples available at the research biobank at the Parker Institute, Copenhagen University Hospital at Frederiksberg and Bispebjerg, Denmark. ^A Only patients treated with adalimumab or infliximab were included, as we did not have access to a reliable detection method regarding antibodies towards etanercept. ^B Vials were adequate only if they had not been previously thawed. At baseline, one vial of ≥ 3μl was required, and at 6 months follow-up 2 vials of ≥ 3 μl were required. ^C Missing samples due to inclusion in project not requiring 6 months sampling, termination of current treatment, or lost to follow-up.</p

Serum TNFi levels in relation to antibodies against adalimumab and infliximab following six months of treatment.

<p>Antibodies towards the prescribed TNFi (anti-TNFi Abs) were measured in 26 patients with rheumatoid arthritis, using radioimmunoassay. Patients were treated with either adalimumab (A) or infliximab (B). Functional levels of TNFi were determined using reporter gene assays. Presence of anti-TNFi Abs correlated with lower levels of TNFi for both drugs *(<i>p</i> < 0.05). Medians and interquartile ranges are shown.</p

Clinical variables and biomarkers according to whether TNFi was detectable in the patients’ blood following 6 months of treatment with adalimumab or infliximab.

<p>Clinical variables and biomarkers according to whether TNFi was detectable in the patients’ blood following 6 months of treatment with adalimumab or infliximab.</p

Baseline characteristics of the 26 rheumatoid arthritis patients included in the study.

<p>Baseline characteristics of the 26 rheumatoid arthritis patients included in the study.</p

Sensitivity analyses: Comparison of pressure-pain threshold (PPT) and temporal summation (TS) changes at weeks 14 and 26 using baseline observation carried forward (BOCF) imputation and complete-case population (no imputations).

<p>Sensitivity analyses: Comparison of pressure-pain threshold (PPT) and temporal summation (TS) changes at weeks 14 and 26 using baseline observation carried forward (BOCF) imputation and complete-case population (no imputations).</p